Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy
PaperCitations, authors & open-access status
A randomized phase III study evaluating the efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 249 citations, 2014 year and bronze oa status.
249
Citations
2014
Year
bronze
OA Status